Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 5:23 PM
Ignite Modification Date:
2025-12-26 @ 5:23 PM
NCT ID:
NCT02047006
Eligibility Criteria:
Inclusion Criteria:
* age ≥18 year
* signed informed consent
* chronic hemodialysis patients without immediate life-threatening conditions, dialysed three times a week for at least three months
* requiring anticoagulation for the prevention of deep venous thrombosis
Exclusion Criteria:
* residual renal function, as defined by a residual diuresis of \>50 ml/day
* known intestinal malabsorption
* inability to take oral medication
* mechanical heart valve
* inability to stop co-medication that causes major interactions with rivaroxaban (e.g. ketoconazole, itraconazole, voriconazole, posaconazole, ritonavir)
* severe liver dysfunction Child-Pugh grade C
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02047006
Study Brief:
Protocol Section:
NCT02047006